Multifocal abscesses due to multiresistant Escherichia coli after transrectal ultrasound-guided prostate biopsy

Medical Journal of Australia

Volumn 198, Issue 5, 2013, Pages 282-284

  Roberts, Matthew J ^a,b   Parambi, Anisha ^a   Barrett, Lucinda ^b   Hadway, Paul ^a   Gardiner, Robert A Frank ^a,b   Hajkowicz, Krispin M ^a   Yaxley, John ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFAZOLIN; CEFTRIAXONE; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; MEROPENEM; NITROFURANTOIN; TOBRAMYCIN; TRIMETHOPRIM;

ABSCESS; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISKITIS; DRUG DOSE INCREASE; EPIDURAL ABSCESS; ESCHERICHIA COLI INFECTION; HUMAN; HUMAN TISSUE; INFUSION SYSTEM; LUMBAR DISCITIS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; POSTOPERATIVE INFECTION; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY;

ABSCESS; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OBESITY, MORBID; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84876753626     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja12.11719     Document Type: Article

References (11)

1. Carignan A, Roussy J-F, Lapointe V, et al. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 2012; 62: 453-459.
2. Loeb S, Carter HB, Berndt SI, et al. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011; 186: 1830-1834.
3. Bowden FJ, Roberts J, Collignon PJ. Prostate cancer screening and bacteraemia [letter]. Med J Aust 2008; 188: 60.
4. Batura D, Rao GG. The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother 2013; 68: 247-249.
5. Williamson DA, Masters J, Freeman J, Roberts S. Travel-associated extended-spectrum β-lactamase-producing Escherichia coli bloodstream infection following transrectal ultrasound-guided prostate biopsy [letter]. BJU Int 2012; 109: E21-E22.
6. Hsueh P-R, Hoban DJ, Carmeli Y, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011; 63: 114-123.
7. Antibiotic Expert Group. Therapeutic guidelines: antibiotic, version 14. In: eTG complete. Melbourne: Therapeutic Guidelines Limited, 2010. http://www.tg.org.au/index.php?sectionid=71 (accessed Feb 2013).
8. Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis 2008; 46: 1069-1077.
9. Galfano A, Novara G, Iafrate M, et al. Prostate biopsy: the transperineal approach. EAU-EBU Update Series 2007; 5: 241-249. doi: 10.1016/j.eeus.2007.08.001.
10. Abughosh Z, Margolick J, Goldenberg SL, et al. A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol 2012; Oct 3. pii: S0022-5347(12)05130-0. doi: 10.1016/j.juro.2012.09.121. [Epub ahead of print.]
11. Taylor AK, Zembower TR, Nadler RB, et al. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 2012; 187: 1275-1279.